ISA Pharmaceuticals Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Out of Business

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Liquidation

ISA Pharmaceuticals General Information

Description

Developer of synthetic therapeutic vaccines designed to provide treatment for cancer. The company's vaccines are based on proprietary synthetic long peptide technologies that provide treatment for cancer and persistent viral infections, enabling patients with treatment to have a likelihood of success.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Leiden Bio Science Park
  • De Limes 7
  • 2342 DH Oegstgeest
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Leiden Bio Science Park
  • De Limes 7
  • 2342 DH Oegstgeest
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ISA Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Bankruptcy: Liquidation 18-Jul-2024 Completed Bankruptcy: Liquidation
9. Secondary Transaction - Private Completed Clinical Trials - Phase 2
8. Later Stage VC 15-Dec-2022 Completed Clinical Trials - Phase 2
7. Later Stage VC (Series B) 06-Jul-2021 Completed Clinical Trials - Phase 2
6. Later Stage VC 17-Jun-2020 Completed Clinical Trials - Phase 2
5. Debt - General 28-Jun-2019 Completed Clinical Trials - General
4. Secondary Transaction - Private Completed Clinical Trials - General
3. Later Stage VC 07-Jan-2013 Completed Clinical Trials - General
2. Grant $27.3M $14.8M Completed Startup
1. Early Stage VC (Series A) 01-Jan-2004 $14.8M $14.8M Completed Startup
To view ISA Pharmaceuticals’s complete valuation and funding history, request access »

ISA Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of synthetic therapeutic vaccines designed to provide treatment for cancer. The company's vaccines are based o
Drug Discovery
Oegstgeest, Netherlands
21 As of 2024

Schlieren, Switzerland
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ISA Pharmaceuticals Competitors (7)

One of ISA Pharmaceuticals’s 7 competitors is Virometix, a Venture Capital-Backed company based in Schlieren, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Virometix Venture Capital-Backed Schlieren, Switzerland
Inotrem Venture Capital-Backed Paris, France
F-Star Therapeutics Formerly VC-backed Cambridge, United Kingdom
Scancell Holdings Formerly VC-backed Oxford, United Kingdom
Theravectys Venture Capital-Backed Paris, France
You’re viewing 5 of 7 competitors. Get the full list »

ISA Pharmaceuticals Patents

ISA Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025008085-A1 Immunotherapy for the treatment of prame-expressing cancers Inactive 05-Jul-2023
WO-2024223299-A2 Methods of treating cancer by administering immunogenic compositions and a pd-1 inhibitor Inactive 26-Apr-2023
WO-2024223299-A3 Methods of treating cancer by administering immunogenic compositions and a pd-1 inhibitor Inactive 26-Apr-2023
WO-2024149888-A1 Improved lipopeptide quantification Inactive 12-Jan-2023
WO-2024079311-A1 Modified long peptides suitable for use in immunisation Inactive 13-Oct-2022 A61K39/12
To view ISA Pharmaceuticals’s complete patent history, request access »

ISA Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ISA Pharmaceuticals FAQs

  • When was ISA Pharmaceuticals founded?

    ISA Pharmaceuticals was founded in 2004.

  • Where is ISA Pharmaceuticals headquartered?

    ISA Pharmaceuticals is headquartered in Oegstgeest, Netherlands.

  • What is the size of ISA Pharmaceuticals?

    ISA Pharmaceuticals has 21 total employees.

  • What industry is ISA Pharmaceuticals in?

    ISA Pharmaceuticals’s primary industry is Drug Discovery.

  • Is ISA Pharmaceuticals a private or public company?

    ISA Pharmaceuticals is a Private company.

  • What is ISA Pharmaceuticals’s current revenue?

    The current revenue for ISA Pharmaceuticals is .

  • How much funding has ISA Pharmaceuticals raised over time?

    ISA Pharmaceuticals has raised $84M.

  • Who are ISA Pharmaceuticals’s competitors?

    Virometix, Inotrem, F-Star Therapeutics, Scancell Holdings, and Theravectys are some of the 7 competitors of ISA Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process